Essex Financial Services Inc. bought a new position in shares of Henry Schein Inc. (NASDAQ:HSIC) during the second quarter, Holdings Channel reports. The firm bought 1,150 shares of the company’s stock, valued at approximately $203,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of HSIC. Ngam Advisors L.P. purchased a new position in shares of Henry Schein during the first quarter worth approximately $1,749,000. TIAA CREF Investment Management LLC raised its position in shares of Henry Schein by 5.8% in the first quarter. TIAA CREF Investment Management LLC now owns 296,985 shares of the company’s stock worth $51,269,000 after buying an additional 16,247 shares during the last quarter. Carnick & Kubik LLC purchased a new position in shares of Henry Schein during the first quarter worth approximately $1,447,000. Meiji Yasuda Asset Management Co Ltd. raised its position in shares of Henry Schein by 60.0% in the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 2,586 shares of the company’s stock worth $446,000 after buying an additional 970 shares during the last quarter. Finally, Canada Pension Plan Investment Board raised its position in shares of Henry Schein by 214.1% in the first quarter. Canada Pension Plan Investment Board now owns 26,101 shares of the company’s stock worth $4,506,000 after buying an additional 17,791 shares during the last quarter. Institutional investors and hedge funds own 91.98% of the company’s stock.
Shares of Henry Schein Inc. (NASDAQ:HSIC) traded down 0.84% during mid-day trading on Thursday, hitting $157.12. The stock had a trading volume of 370,874 shares. The firm has a market cap of $12.85 billion, a PE ratio of 26.62 and a beta of 1.05. Henry Schein Inc. has a 52 week low of $140.11 and a 52 week high of $183.00. The stock has a 50 day moving average price of $162.49 and a 200 day moving average price of $170.27.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Thursday, August 4th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.63 by $0.01. The business earned $2.87 billion during the quarter, compared to the consensus estimate of $2.85 billion. Henry Schein had a return on equity of 17.84% and a net margin of 4.42%. The firm’s quarterly revenue was up 9.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.46 EPS. Equities research analysts expect that Henry Schein Inc. will post $6.57 EPS for the current fiscal year.
HSIC has been the subject of a number of recent research reports. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Tuesday, July 5th. Bank of America Corp. started coverage on Henry Schein in a research note on Monday, September 12th. They issued a “buy” rating and a $185.00 target price for the company. Robert W. Baird reiterated an “outperform” rating and set a $176.00 price objective (up from $175.00) on shares of Henry Schein in a research note on Tuesday, October 4th. Finally, Goldman Sachs Group Inc. upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective for the company in a research note on Tuesday. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $160.50.
In related news, Director Paul Brons sold 3,381 shares of the business’s stock in a transaction on Monday, August 29th. The stock was sold at an average price of $164.03, for a total value of $554,585.43. Following the completion of the sale, the director now directly owns 13,715 shares in the company, valued at approximately $2,249,671.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.27% of the stock is owned by corporate insiders.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.